School of Pharmacy Awarded Grant to Design New Chemotherapy for Aggressive Cancers
CHARLESTON, W.VA.- The University of Charleston School of Pharmacy (UCSOP) has received a $30,000 grant from the West Virginia IDeA Network of Biomedical Research Excellence. (WV-INBRE) This funding will be used to study the enzymology and regulation of the histone deacetylase 3 (HDAC3) to assist in the development of chemotherapy for aggressive forms of cancer including pancreatic ductal adenocarcinoma. Student researchers at the University of Charleston will participate in drug design and finding HDAC3 inhibitors.
Gregory Polsinelli, assistant professor, will be the principal investigator of this project alongside student researchers and collaborator Faruk Khan, interim dean of UCSOP. Marshall University will also provide assistance.
“I am very grateful for the grant award provided by WV-INBRE. The funding will allow my lab to train approximately three students in the fields of enzymology and cancer epigenetics, Polsinelli said. “Undergraduate and pharmacy students will have the opportunity to complete research in my laboratory this Spring and Summer.”